Interference of kallikrein 1b26 (klk1b26) translation by microRNA specifically expressed in female mouse submandibular glands: an additional mechanism for sexual dimorphism of klk1b26 protein in the glands
© Kurihara et al; licensee BioMed Central Ltd. 2011
Received: 28 May 2011
Accepted: 16 November 2011
Published: 16 November 2011
Mouse kallikrein 1b26 (klk1b26) protein is more abundant in male submandibular glands (SMGs) than in female ones. This sexual dimorphism has been thought to be due to increased mRNA synthesis stimulated by androgen. However, the klk1b26 protein level in female SMG is far less than that expected from the mRNA level, suggesting an additional mechanism for down-regulation of klk1b26 expression in female SMGs.
We examined the effects of small non-coding RNAs in mouse SMGs on in vitro translation of klk1b26 using a reticulocyte lysate system and reverse transcription (RT)-PCR for klk1b26 mRNA. Statistical analyses were performed with a computer package (Microsoft Excel).
The microRNA (miRNA) preparation from female SMGs, but not male SMGs, interfered with the in vitro translation of the klk1b26 protein and inhibited the RT-PCR for klk1b26 mRNA with forward primers targeting its 5'-terminal region (between the 15th and 40th nucleotide from the 5'-terminal). The miRNA preparation from castrated mouse SMGs showed the inhibitory effect on the klk1b26 translation, but that from a 5α-dihydrotestosterone-treated female mouse SMGs did not. Synthetic miRNAs (miR-325 and miR-1497a), which have partial complementarity with klk1b26 mRNA at its 5'-terminal region (15th to 40th nucleotide position from the 5'-terminal), also interfered with the in vitro klk1b26 translation. When the female miRNA preparation was incubated with a 30-nucleotide-long single-strand oligoDNA (named [15th-44th]ssDNA, whose sequence corresponded to the 15th to 44th position from the 5'-terminal of klk1b26 mRNA) prior to the addition into the in vitro translation system, the inhibitory effect of the miRNA preparation on klk1b26 translation disappeared, while [15th-44th]ssDNA itself had no effect on the translation. Preincubation of the miRNA preparation with another single-strand DNA ([169th-198th]ssDNA, whose sequence corresponded with 169th to 198th position of klk1b26 mRNA) did not show the inhibitory effect.
The small non-coding RNA, most probably miRNA, specifically expressed in female mouse SMGs interfered with klk1b26 protein synthesis in the in vitro translation system. Therefore sexual dimorphism observed in klk1b26 expression in mouse SMGs is due at least in part to the female-specific small non-coding RNA in SMGs.
Keywordskallikrein klk1b26 microRNA salivary gland sex difference testosterone translation
It is known that the submandibular gland (SMG) of the male mouse contains many important bioactive substances such as nerve growth factor (NGF), epidermal growth factor (EGF), renin, and members of the kallikrein (klk) gene family [1–3]. Among these kallikrein isozymes, klk1, klk9, klk22, and klk1b26 have been identified as true tissue kallikrein, EGF-binding protein, β-NGF endopeptidase, and prorenin-converting enzyme, respectively [4, 5]. One of the most prominent characteristics of these bioactive substances in mouse SMGs is the sex difference in their content [4–8]. The expression of klk9, klk22, and klk1b26 proteins in the ICR mouse is androgen responsive: the contents of these kallikreins are much higher in the male SMG than in the female one, castration decreases their contents to levels similar to the female ones, and 5α-dihydrotestosterone administration to females or castrated animals increases the content of these proteins [4–6]. This sex difference is thought to be due to increased mRNA synthesis stimulated by androgen [9, 10]. However, we still have little information about the post-transcriptional regulation of klk1b26 protein in female mouse SMGs. The difference between klk1b26 mRNA levels in male and female mouse SMGs detected by reverse transcription (RT)-PCR does not seem large enough to fully account for the difference in klk1b26 protein levels between male and female SMGs. Furthermore, we observed that a small non-coding RNA fraction prepared from female mouse SMGs, but not male ones, inhibited PCR product formation for klk1b26 mRNA in RT-PCR .
For more than a decade, numerous studies have accumulated showing that small non-coding RNAs typically such as microRNAs (miRNAs), played important roles in controlling gene expression via post-transcriptional regulation. MicroRNAs are RNA molecules, 21 to 23 nucleotides in length, involved in post-transcriptional gene silencing mediated by the RNA interference pathway [12–21]. They are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nucleotide stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the sense miRNA and antisense miRNA star (miRNA*) products. The mature miRNAs (either sense or antisense sequences, or occasionally both sequences) play important roles in the regulation of translation and degradation of target mRNAs through base pairing to partially complementary sites in the 3'-untranslated regions (3'-UTR) of the mRNAs . Post-translational regulation of protein expression by mature miRNA that interacts with its target mRNA at sites other than the 3'-UTR, for example at the coding region, has also been reported .
In the present study, we examined the effects of miRNA preparations from male and female SMGs on klk1b26 protein synthesis. We found that the female miRNA preparation, but not the male one, interfered with in vitro klk1b26 translation in a reticulocyte lysate system. The female miRNA preparation also inhibited PCR product formation only when primer pairs targeting 5'-terminal regions of the klk1b26 mRNA were used. Furthermore, synthetic small RNAs (20 to 23 nucleotides long) having partial homology with the complementary sequence at the 5'-terminal region of klk1b26 mRNA showed similar effects as the female miRNA preparation on the klk1b26 translation in vitro. The interfering effect of the female miRNA preparation on klk1b26 translation was lost by incubating it with a 30-nucleotide-long single-strand DNA whose sequence corresponded to the 5'-terminal region of klk1b26 mRNA sequence prior to the in vitro translation reaction, while the single-strand DNA itself had no effect on the klk1b26 translation. These results suggest that small non-coding RNAs such as miRNA specifically expressed in female SMGs are involved, at least in part, in the sexual dimorphism of klk1b26 expression in the mouse SMG.
Animals and treatments
ICR mice were purchased from Tokyo Laboratory Animal Science Co. Ltd. (Tokyo, Japan). All experiments were carried out in accordance with the guidelines for animal experiments of Meikai University. All animals were killed at 12 weeks of age for all of the experiments. Castration was carried out under ether anesthesia 4 weeks before hormone treatments. 5α-Dihydrotestosterone (DHT) was suspended in sesame oil. All hormone injections were made subcutaneously six times with a 1-day interval at a dose of 20 mg/kg DHT. At 1 day after the last hormone injection, the animals were killed by cervical dislocation and their SMGs were removed .
Total RNA and miRNA were prepared with a Micro-to-Midi Total RNA Purification System and a PureLink miRNA Isolation Kit, respectively (Invitrogen Life Technologies, Carlsbad, CA, USA) according to the manufacturer's instructions [22–24]. One sample of total RNA or of miRNA preparation was prepared from the SMGs of one mouse. Messenger RNA was prepared with a MicroPoly(A)Purist Small Scale mRNA Purification Kit (Ambion, Austin, TX, USA).
Exo-mRNA fraction preparation
The exo-mRNA fraction was prepared by removing poly(A)-containing RNA from the total RNA by using oligo(dT) cellulose from a MicroPoly(A)Purist Small Scale mRNA Purification Kit (Ambion, no. AM1919). In brief, total RNAs prepared from SMGs of three mice were combined and mixed with a premeasured aliquot of oligo(dT) cellulose in binding solution, and the mixture was incubated to allow hybridization between the poly(A) sequences and oligo(dT) cellulose. The oligo(dT) cellulose was transferred to a spin column and eluted with non-binding solution. The exo-mRNA fraction in the flow-through solution was concentrated by using a Micro-to-Midi Total RNA Purification System Kit.
Reverse transcriptase reactions were carried out with a SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen Life Technologies). In all experiments, the first-strand cDNAs were synthesized by using the oligo(dT) primer and then subjected to RNase H digestion [22–24]. PCR primers for mouse klk1b26 mRNA (GenBank: NM 010644) were designed based on the cDNA sequences registered in the Query Gene Bank Database, National Center for Biotechnology. Total RNAs (200 ng each) from tissues were used for the RT-PCR with Super Mix High Fidelity DNA Polymerase (Invitrogen Life Technologies), and PCR was performed with a Gene Amp 9600 PCR System (Perkin Elmer, Foster City, CA, USA) according to the following schedule: denaturation, annealing, and elongation at 94°C for 30 s, 55°C for 30 s, and 68°C for 60 s, respectively, for 25 cycles. Amplified PCR products were separated electrophoretically in agarose gels. Sequences of PCR products were confirmed to be identical to the corresponding positions of the cDNA sequences.
Nucleotide sequence of primers and oligonucleotides used in the experiments
Name of primers/oligonucleotides
Corresponding position on klk1b26 mRNA (NM 010644)
F1 (forward primer)
F11 (forward primer)
F15 (forward primer)
F21 (forward primer)
F24 (forward primer)
F40 (forward primer)
F100 (forward primer)
F169 (forward primer)
R552 (reverse primer)
R609 (reverse primer)
21-40 (partly complementary)
12-28 (partly complementary)
Sequence analysis of PCR products
For the sequence analysis, PCR products were reamplified with their respective primers in the presence of a dye terminator (BigDye Terminator Cycle Sequencing FS Ready Reaction Kit, no. 4303573; Perkin Elmer, Branchburg, NJ, USA) [22–24]. The DNA sequences were analyzed with an ABI PRISM 310 Genetic Analyzer (Perkin Elmer, Foster City, CA, USA).
Sequence analysis of klk1b26 mRNA 5'-terminus by rapid amplification of cDNA ends (RACE)
The klk1b26 mRNA 5'-terminus was analyzed by use of a 5' RACE System, Version 2.0 (Invitrogen Life Technologies) according to the manufacturer's instructions. First-strand DNAs were synthesized from total RNAs in mouse SMGs by using a gene-specific reverse primer, 5'-taggtagactttggcacagttctc-3' (nucleotide positions 586 to 609, R609). A homopolymeric tail was added to the 3'-end of the cDNA by using terminal dioxynucleotidyl transferase (TdT) and dCTP. PCR amplification was accomplished by using Taq DNA polymerase with a primer pair of a nested gene-specific reverse primer (5'-tttggcacagttctcattgg-3': nucleotide positions 581 to 600, R600) and abridged anchor primer. The PCR product was reamplified with a primer pair of a nested gene-specific reverse primer (5'-atcatctggcttttgccatc-3' nucleotide positions 533 to 552, R552) and abridged universal anchor primer, resulting in the RACE product. The sequences of the RACE products were analyzed as described in the Sequence analysis of PCR products section below [22–24].
SMG extract preparation for RNA degrading activity
SMGs were homogenized in buffer comprising 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hepes) (pH 7.3), 110 mM potassium acetate, 1 mM magnesium acetate, 2 mM CaCl2 and 1 mM dithiothreitol with a Teflon pestle glass homogenizer (Potter Elvehjem type). The homogenate was centrifuged at 29,700 g for 30 min, and the resulting supernatant was used for experiments.
Preparation of anti-klk1b26 antibody and immunoprecipitation of klk1b26 protein
The klk1b26 protein was purified as described previously : in brief, male mouse SMGs were homogenized in 20 mM Tris/HCl (pH 7.5) with a Teflon pestle glass homogenizer (Potter Elvehjem type). The homogenate was centrifuged at 105,000 g for 60 min, and the resulting supernatant was adjusted to pH at 4.5 with acetic acid. After centrifugation, the soluble fraction was neutralized with KOH, and then treated with 40% to 60% acetone. The precipitated protein was applied to isoelectric fractionation by the method of Vesterberg and Svensson . The klk1b26 protein was isolated at pI 9.9 . Anti-klk1b26 antiserum was obtained by immunizing a rabbit with the purified pI 9.9 protein as immunogen.
The antibody, preconjugated to protein G-beads, was incubated with the reticulocyte lysate mixture for 2 h in phosphate-buffered saline (PBS)/1% ovalbumin containing 1/100 × protease inhibitor cocktail (no. 535140; Calbiochem, La Jolla, CA, USA) for immunoreaction with the protein [8, 26]. The immunoprecipitated protein was applied to non-reducing SDS-PAGE (16% polyacrylamide gel). Autoradiography was conducted on the dried gels.
In vitro translations of klk1b26 protein and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) with reticulocyte lysate
Protein synthesis by in vitro translation with a reticulocyte lysate system was carried out by using a Retic Lysate IVT for in vitro translation of mRNA (Ambion). Messenger RNA (500 ng) purified from male SMGs in an 11.2 μl translation mixture containing 1.4 μl of [35S]methionine (no. NEG709A; Perkin Elmer, Waltham, MA, USA) was mixed with 23.8 μl of reticulocyte lysate and incubated for 2 h at 30°C. When the effects of miRNA preparations from SMGs were examined, the mRNA (500 ng) purified from male SMGs was preincubated with miRNA preparations from male or female SMGs (final concentration of 90 or 30 ng/ml each for Figure 4C, D, and of 90 ng/ml each for Figure 4E, F) for 30 min at 4°C in a 11.2 μl translation mixture containing [35S]methionine (no. NEG709A; Perkin Elmer, Waltham, MA, USA). When the effects of miRNAs or antisense RNA (asR-F21) were examined, the mRNA preparation was preincubated with either of the synthetic miRNAs or asR-F21 in the translation mixture prior to mixing with the reticulocyte lysate. The translation reaction was stopped by adding 3.5 μl of Ambion RNase Cocktail Enzyme Mix (no. AM2286). Proteins synthesized in the in vitro system were mixed with anti-klk1b26 antibody or anti-GAPDH antibody (sc-25778; Santa Cruz Biotechnology, Santa Cruz, CA, USA) preconjugated to protein G-beads (no. 22851; Pierce Biotechnology, Rockford, IL, USA) and incubated for 2 h in PBS/1% ovalbumin containing 1/100 × protease inhibitor cocktail (no. 535140, Calbiochem). The immunoprecipitated protein was subjected to non-reducing SDS-PAGE (16% polyacrylamide gel). Autoradiography was conducted on the dried gels. Quantitative determination of density of the [35S]klk1b26 protein and [35S]GAPDH protein bands was performed by computer assisted image analysis of the autoradiograms.
Preincubation of the female miRNA preparation with single-strand DNA for hybridization
MicroRNA preparations (3.5 μg) from female mouse SMG were incubated with 40 pmol chemically synthesized single-strand DNA, [15th-44th]ssDNA or [169th-198th]ssDNA, in 4 μl incubation mixtures containing 80 mM CH3COOK, 0.5 mM MgCl2 and 10 mM creatine phosphate (pH 7.4) at 80°C for 1 min and then slowly cooled down to 4°C in 10 min. The sequences of the single-strand DNAs are described in Table 1.
Western blot analysis
SMGs were homogenized with a Teflon pestle glass homogenizer (Potter Elvehjem type) in 0.25 M sucrose containing 1/100 volume Proteinase Inhibitor Cocktail Set III (no. 535140; Calbiochem, Darmstadt, Germany). The homogenate was centrifuged at 29,700 g for 30 min, the resulting supernatant was subjected to non-reducing SDS-PAGE (16%), and the separated proteins were electrophoretically transferred onto polyvinylidene difluoride (PVDF) membrane filters. The filters were then stained immunochemically. In brief, filters were blocked with 5% skimmed milk in 10 mM Tris/HCl, pH 7.4, containing 150 mM NaCl and 0.05% Tween 20 (T-TBS) at room temperature for 45 min and then incubated for 1 h with the anti-klk1b26 antibody in T-TBS containing 5% skimmed milk. After having been washed with T-TBS, these filters were incubated for 1 h with anti-rabbit IgG goat serum conjugated with horseradish peroxidase (SC-2054; Santa Cruz Biotechnology). The filters were then washed, and the signal was detected with ECL Plus western blotting detection reagents (RPN 2132; Amersham, Buckinghamshire, England) [22–24].
Statistical analyses were performed with a computer package (Microsoft Excel; Microsoft, Redmond, WA, USA). Data were presented as means ± SD. Levels of statistical significance between means were calculated by the two-tailed Student's t test.
klk1b26 protein and RT-PCR of klk1b26 mRNA in mouse submandibular glands (SMGs)
PCR product formation with F21 and F169 forward primers for klk1b26 mRNA from SMG and effects of castration and testosterone administration on the PCR signal strength
Since a clear sex difference in the PCR signals for klk1b26 mRNA levels in SMGs was detected with the F21/R552 or F15/R552 primer pair, we examined whether the signal strength was affected by androgen. The first-strand cDNAs were prepared by using oligo(dT) primer and total RNA from SMGs of experimental animals. Both primer pairs having the F21 forward primer, F21/R552 and F21/R609, gave a clear sex difference in the PCR signals; the effect of androgen, that is, castration or DHT administration to females or castrated mice, on the signal strength was clearly observed with these primer pairs (Figure 2B). However, when PCR was performed with the F169 forward primer (primer pairs of F169/R552 and F169/R609), a much smaller difference in the PCR signals for the mRNA levels between male and female SMGs was found (Figure 2C). Also, there were only small differences in the PCR signals for klk1b26 mRNA in SMGs between males and castrated males or those given DHT, and in SMGs between females and DHT-administered females.
Nucleotide sequences at the 5'-terminal regions of klk1b26 mRNAs from male and female SMGs and effect of incubation with SMG extracts on the mRNA
We then examined the nucleotide sequence of klk1b26 mRNAs from male and female SMGs by use of the 5' RACE method, since the results of experiments shown in Figures 1 and 2 suggested the possibility that klk1b26 mRNA in SMGs of females and castrated mice had undergone some post-transcriptional modification near its 5'-terminal region, somewhere between the 15th and 40th nucleotide. However, we unexpectedly obtained the same nucleotide sequences for both the male and female mRNAs from their 5'-terminal to 40th nucleotide, 5'-agctccaagctcactgcctgcagttcctggacacctgtta-3', which coincided with the corresponding part of the registered klk1b26 mRNA sequence (GenBank: NM 010644, Figure 3A), indicating no modification in the 5'-terminal region of klk1b26 mRNA in female SMGs.
We also examined protein extracts from male and female SMGs for any activity modifying klk1b26 mRNA (Figure 3B). In vitro incubation of the total RNA prepared from male SMGs with cell-free extracts of either male or female SMGs decreased the PCR signals obtained with the F21/R552 primer pair. However, the PCR signals with the F169/R552 primer pair were not so strongly affected by the SMG extracts from male or female, suggesting that the 57-terminal region of klk1b26 mRNA might be more fragile or susceptive to RNA degradation than its middle region. However, a significant difference in mRNA degrading activities was not detected between the male and female SMG extracts.
Effects of miRNA preparations from mouse SMGs on in vitro translation of klk1b26 mRNA
The interfering substance in the female total RNA preparations somehow acted in a sequence-specific manner and was assumed to be a form of small non-coding RNA contaminating in the total RNA preparations. Since small non-coding RNAs such as miRNA are known to play important roles in controlling gene expression, we prepared miRNA fractions from male and female mouse SMGs and examined their effects on klk1b26 protein synthesis. In the in vitro translation system composed of reticulocyte lysate with mRNAs purified from male SMGs, the female miRNA preparation dose dependently inhibited the synthesis of klk1b26 protein (Figure 4C, D): the autoradiogram signal of the klk1b26 protein in the presence of the female miRNA decreased to 50% to 70% of that of the protein in the absence of the miRNA preparation. However, the male miRNA preparation did not have such an inhibitory effect on the in vitro klk1b26 translation (Figure 4C, D). In the control experiments, a slight decrease in GAPDH translation was sometimes observed by the addition of the miRNA preparations. However, the effects of both the miRNA preparations from male SMGs and female ones on the synthesis of GAPDH protein synthesis were not at significant levels (Figure 4E, F). Additionally, there was no significant difference in the effects of male and female miRNA preparations on the GAPDH translation.
Effect of miRNA preparation on RT-PCR of klk1b26 mRNA
Effects of androgen on miRNAs in mouse SMGs
Effects of synthetic RNAs partially complementary with the 5'-region of klk1b26 mRNA on in vitro translation of klk1b26 protein
When the effects of these synthetic RNAs on the RT-PCR for klk1b26 mRNA were tested using three sets of primer pairs as shown in Figure 7C, PCR product formation was inhibited by respective RNAs only when the F21 forward primer was employed but not with the F40 or F100 primers.
Masking of the translation-interfering activity in the female miRNA preparation by specific single-strand DNA
Mouse klk1b26, a prorenin-converting enzyme, is a member of the klk gene family  and is much more abundantly expressed in the SMGs of male mice than in females [6, 7]. This sex difference in klk1b26 protein expression has been thought to be due to stimulated transcription of the klk1b26 gene in the SMG by androgen [9, 10]. However, we found that when the klk1b26 protein and its mRNA levels in the male and female mouse SMGs were compared based on the wet weight of the glands, the mRNA levels in female SMGs were as much as 20% of that in male SMGs, while klk1b26 protein levels in the female glands were less than 6% of that in the male glands. Thus, we conceived the idea that there was an as yet unidentified mechanism, most probably post-transcriptional, down-regulating klk1b26 expression in the female SMG.
We reexamined klk1b26 mRNA levels in male and female SMGs by RT-PCR using various primer pairs targeting various regions of the mRNA, and found that the klk1b26 mRNA level in female total RNA preparations was estimated to be extremely low compared to that of male total RNA preparations only when the RT-PCR was performed with forward primers targeted near the 5'-terminal region of the mRNA (F15 and F21 primers, where the 5'-nucleotides corresponded to the 15th and 21st nucleotides of klk1b26 mRNA (GenBank: NM 010644), respectively) than when other forward primers targeting other regions of the mRNA were used (Figure 2). The inefficiency of the PCR product formation by F15 or F21 forward primers with the total RNA from female SMGs was not due to the modification of klk1b26 mRNA in female SMGs, because klk1b26 mRNAs from both male and female SMGs had the same nucleotide sequence according to the results of 5' RACE analysis (Figure 3A). The PCR products from male and female total RNA preparations with various primer pairs were subjected to DNA sequencing analysis and confirmed to be identical with the corresponding position of the klk1b26 mRNA sequence. Also, transcript variants for klk1b26 have not been reported/registered in the GenBank database. These results, therefore, suggest that female SMGs contained some inhibitory RNA molecules that interfered with the PCR process in a sequence-specific manner. The results of experiments with the 'exo-mRNA fraction' (Figure 4A, B) also supported this assumption.
Next, we examined the effects of miRNA from mouse SMGs on klk1b26 translation using the in vitro reticulocyte lysate system, because miRNAs arguably plays regulatory roles in gene expression and because such miRNA could be expected to interfere with the PCR reaction in a sequence-specific manner. The miRNA preparations from mouse SMGs prepared by using a PureLink miRNA Isolation Kit (Invitrogen Life Technologies) might contain small RNAs of < 200 nucleotides long other than miRNAs. The female miRNA preparation, but not the male one, inhibited the synthesis of klk1b26 protein in the in vitro translation system (Figure 4C, D). GAPDH translation in the same in vitro system was scarcely decreased by either the miRNA preparation from male or female, but the effects were not at significant levels. Differences between the effects of male and female miRNA preparations on GAPDH translation were not statistically significant. Since the klk1b26 translation interfering RNA was specifically observed in female mouse SMGs, the effects of castration and DHT administration to females or castrated mice were tested. The interfering RNA appeared in the SMG miRNA preparations from castrated mice and disappeared in mice who had undergone DHT administration (Figure 6A, B), indicating that expression of the interfering RNA was down-regulated by androgen.
The miRNA preparation from female SMGs also inhibited product formation in RT-PCR when performed with the primer pair (F21/R552) targeting the 5'-terminal region of klk1b26 mRNA, whereas the male miRNA preparation gave only a slight effect (Figure 5A). It should be noted that the inhibitory effect of the female miRNA preparation on the PCR product formation was clear when the F21 forward primer was used, but was not obvious with the F1, F11, F40, F100 (Figure 5C) or F169 forward primers (Figure 5B). These results implied that the length of RNA contained in the female miRNA preparation, which interacted with klk1b26 mRNA and interfered with klk1b26 translation, was not greater than 31 nucleotides long and that the site on the klk1b26 mRNA where the interfering RNA interacted was within 44 nucleotides from the start site of the mRNA (GenBank: NM 010644). We prepared small RNAs of 20 to 23 nucleotides long (chemically synthesized hsa-miR-325, miR-1497a, and asRNA in Figure 7A) which had partial complementarity with klk1b26 mRNA at its 5'-terminal region, and demonstrated that these small RNAs inhibited the in vitro translation of klk1b26 mRNA (Figure 7B). All of these synthetic small RNAs also inhibited the PCR reaction when the primer pair of F21/R552 was used. However, the inhibitory effect of the RNAs on PCR product formation was not detectable when the F40 or F100 forward primers were used in combination with the R552 reverse primer (Figure 7C). Considering the results shown in Figures 5 and 7 together with that shown in Figure 2A where the inhibition of PCR product formation was also observed with the F15 forward primer, it seemed plausible that the interfering RNA in the female miRNA preparation had partial complementarity with klk1b26 mRNA in its 15th to 44th nucleotide position, and its length was not greater than 25 nucleotides long. Therefore, we synthesized 30-nucleotide-long single-strand DNAs, [15th-44th]ssDNA and [169th-198th]ssDNA, of those sequences corresponding with the klk1b26 mRNA sequence at the 15th to 44th and 169th to 198th positions. Preincubation for hybridization of the female miRNA preparation with [15th-44th]ssDNA, but not with [169th-198th]ssDNA used as a negative control, masked/neutralized the activity of the female miRNA preparation in interfering with klk1b26 translation (Figure 8A, B), supporting our assumption.
Translational repression by miRNAs is thought to occur via several mechanisms: RNA-induced silencing complex (RISC)-mediated enhancement of deadenylation and decapping to destabilize the mRNA; sequestering of the mRNA into cytoplasmic bodies (GW-bodies or P-bodies); or disrupting the binding of translation factors to inhibit translation initiation or elongation [18, 21]. When miRNA affects mRNA such as small interfering RNA (siRNA), miRNAs associated with argonaute proteins in the RISC repress protein expression by binding to regions of complementarity with the target mRNAs. The binding sites of miRNAs were typically located within the 3'-UTR of target mRNAs [15, 18–21]. In this case, the seed sequence (second to eighth sequence from the 5'-end) of miRNA was thought to be very important and should be complementally matched with the target mRNA sequence [13, 14]. However, miRNAs were also reported to repress translation by interacting with coding regions of target mRNAs : mouse Nanog, Oct4 and Sox2 genes were demonstrated to have many naturally occurring miRNA targets in their amino acid coding sequence (CDS) and some of those targets were revealed to not contain the miRNA seed. Tay et al.  also reported that the miRNAs interacting at the CDS regions of their target mRNAs had only a limited effect on the mRNA levels but affected the corresponding proteins more substantially. We hypothesized that a kind of miRNA that was specifically expressed in female mouse SMGs interfered klk1b26 translation process contributing to sexual dimorphism of the klk1b26 protein in the mouse SMGs. It is plausible that such a miRNA, which has partial complementarity with the 5'-terminal region of klk1b26 mRNA, inhibits the klk1b26 protein synthesis by disturbing the binding of translation factors needed for translation initiation or elongation, though the effects of other kinds of small non-coding RNA(s) cannot be completely ruled out. In our preliminary experiments on miRNA profiling for male and female mouse SMGs by microarray assay, mmu-miR-325*, which is the mouse counterpart of primate miR-325, was not expressed in high enough levels to estimate whether it was one of the miRNAs expressed in female SMGs rather than in male SMGs. Though the sequence of mmu-miR-325* [29, 30] has two alternative nucleotides compared with that of Homo sapien s (hsa) miR-325, whose sequence is conserved in Macaca mulatta (mml) and Pongo pygmaeus (ppy) [27, 28], mmu-miR-325* is one of the plausible candidates. Additionally, there might be considerable numbers of miRs that have not yet been found and/or registered in miR database. Further analysis should be carried out for the identification of the miRNA(s) involved in the regulation of klk1b26 expression.
SMGs of male mice but not those of female mice produce various proteins with important biological activities [1–3]. Their expression is androgen dependent [1, 6, 7, 9, 10], and some of them are also responsive to thyroid hormone [6–10, 32, 33]. As implied in the present study, this sex difference observed in mouse SMGs is attributed, at least in part, to the miRNA(s) specifically expressed in the female SMG. More than 900 mature miRNAs are on file for human miRNAs in the miRNA database (miRBase release 16, September 2010; http://www.mirbase.org/) and over 60% of human protein-coding genes are thought to be targeted by miRNAs . Since miRNAs play critical roles for the normal functioning of cells, dysregulation of miRNA is thought to be associated with many diseases. Many miRNAs are reported to have links with cancer , heart disease , and dysfunctions in the nervous system . Among them are those for sex-specific diseases such as breast cancer [38, 39], ovarian cancer [40, 41], and prostate cancer . The detailed mechanisms of the miRNA effects on those diseases largely remain to be elucidated. Furthermore, sexual dimorphism is observed not only in the diseases of reproduction-related organs but also in the prevalence and severity of many common diseases such as cardiovascular diseases, autoimmune diseases, asthma, Alzheimer's disease, and Parkinson's disease . The sexual dimorphism observed in disease traits is thought to result from differential gene regulation in males and females, particularly with respect to sex hormone-responsive genes  including those that encode miRNAs.
Among the organs common in males and females, the mouse SMG is one that typically displays sexual dimorphism. It should, therefore, be noted that the mouse SMG is an important model system to investigate further the role and action mechanisms of sex-specific small non-coding RNAs including miRNAs and to uncover the regulatory mechanisms of such sex-specific RNA expression involving androgen and/or estrogen, and occasionally the combination of sex hormones with other hormones.
Mouse klk1b26 protein is more abundant in male SMGs than in female ones; this difference had been thought to be due to only increased mRNA synthesis stimulated by androgen. In the present study a small non-coding RNA, most probably miRNA, specifically expressed in female mouse SMG interfered with klk1b26 protein synthesis in an in vitro translation system. Therefore, interference in the klk1b26 translation process by such a small RNA specifically expressed in females is at least in part involved in the sexual dimorphism of klk1b26 expression in the mouse SMG.
KK works on the board of directors for the Journal of the Japan Salivary Gland Society.
This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science and Culture, Japan (no. 19592157 and no. 18592046) and by a grant from the Miyata Foundation, Meikai University.
- Calissano P, Angeletti PU: Testosterone effect on the synthetic rate of two esteropeptidases in the mouse submaxillary gland. Biochim Biophys Acta 1968, 156: 51–58. 10.1016/0304-4165(68)90103-7PubMedView ArticleGoogle Scholar
- Cohen S: Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 1962, 237: 1555–1562.PubMedGoogle Scholar
- Levi-Montalcini R, Angeletti PU: Nerve growth factor. Physiol Rev 1968, 48: 534–569.PubMedGoogle Scholar
- Gresik EW, Hosoi K, Kurihara K, Maruyama S, Ueha T: The rodent granular convoluted tubule cell: an update. Eur J Morphol 1996, 34: 221–224. 10.1076/ejom.126.96.36.19933PubMedView ArticleGoogle Scholar
- Hosoi K, Tsunasawa S, Kurihara K, Aoyama H, Ueha T, Murai T, Sakiyama F: Identification of mK1, a true tissue (glandular) kallikrein of mouse submandibular gland: tissue distribution and a comparison of kinin-releasing activity with other submandibular kallikreins. J Biochem 1994, 115: 137–143.PubMedGoogle Scholar
- Kurihara K, Maruyama S, Nakanishi N, Sakagami H, Ueha T: Thyroid hormone (3,5,3'-triiodo-l-thyronine) masking/inversion of stimulatory effect of androgen on expression of mk1, a true tissue kallikrein, in the mouse submandibular gland. Endocrinol 1999, 140: 3003–3011. 10.1210/en.140.7.3003Google Scholar
- Kurihara K, Maruyama S, Sakagami H, Ueha T: Differences in androgen-dependent induction of mk1, true tissue kallikrein in C3H/HeN and ICR mouse submandibular gland. Horm Metab Res 1999, 31: 370–374. 10.1055/s-2007-978757PubMedView ArticleGoogle Scholar
- Kurihara K, Moore-Hoon ML, Saitoh M, Turner RJ: Characterization of a phosphorylation event resulting in up regulation of the salivary Na + -K + -2Cl cotransporter. Am J Physiol (Cell Physiol) 1999, 277: C118-C1193.Google Scholar
- McGowan RA, Gross KW, Wilson CM: Effect of androgen and thyroid hormones on renin-1 messenger ribonucleic acid levels in mouse submandibular gland. Mol Cell Endocrinol 1988, 56: 271–276. 10.1016/0303-7207(88)90070-6PubMedView ArticleGoogle Scholar
- Takuma T, Ichida T, Kumegawa M: Regulation of functional mRNA levels for trypsin-like esteroproteases by 5 alpha-dihydrotestosterone and triiodothyronine in mouse submandibular salivary gland. Arch Oral Biol 1985, 30: 727–730. 10.1016/0003-9969(85)90184-0PubMedView ArticleGoogle Scholar
- Kurihara K, Nakanishi N, Tonosaki K: Regulation of kallikrein 1b26 (klk1b26) expression in mouse submandibular gland by post-transcriptional modification of its mRNA. In Proceeding of the XXXVI International Congress of Physiological Sciences (IUPS2009) Function of Life: Elements and Integration: 27 July-1 August 2009; Kyoto. Yoshinori Marunaka: Springer; 2009:530.Google Scholar
- Ambros V: microRNAs: tiny regulators with great potential. Cell 2001, 107: 823–826. 10.1016/S0092-8674(01)00616-XPubMedView ArticleGoogle Scholar
- Hammond SM, Bernstein E, Beach D, Hannon GJ: An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000, 404: 293–296. 10.1038/35005107PubMedView ArticleGoogle Scholar
- Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ: Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 2001, 293: 1146–1150. 10.1126/science.1064023PubMedView ArticleGoogle Scholar
- Khvorova A, Reynolds A, Jayasena SD: Functional siRNAs and miRNAs exhibit strand bias. Cell 2003, 115: 209–216. 10.1016/S0092-8674(03)00801-8PubMedView ArticleGoogle Scholar
- Lee Y, Jeon K, Lee JT, Kim S, Kim VN: MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002, 21: 4663–4670. 10.1093/emboj/cdf476PubMed CentralPubMedView ArticleGoogle Scholar
- Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP: Vertebrate microRNA genes. Science 2003, 299: 1540. 10.1126/science.1080372PubMedView ArticleGoogle Scholar
- Pillai RS, Bhattacharyya SN, Filipowicz W: Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 2007, 17: 118–126. 10.1016/j.tcb.2006.12.007PubMedView ArticleGoogle Scholar
- Ro S, Park C, Young D, Sanders KM, Yan W: Tissue-dependent paired expression of miRNAs. Nucleic Acids Res 2007, 35: 5944–5953. 10.1093/nar/gkm641PubMed CentralPubMedView ArticleGoogle Scholar
- Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD: Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003, 115: 199–208. 10.1016/S0092-8674(03)00759-1PubMedView ArticleGoogle Scholar
- Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I: MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455: 1124–1128. 10.1038/nature07299PubMedView ArticleGoogle Scholar
- Kurihara K, Nakanishi N, Ueha T: Regulation of Na + ,K + -ATPas by cAMP-dependent protein kinase anchored on membrane via its anchoring protein. Am J Physiol (Cell Physiol) 2000, 279: C1516-C1527.Google Scholar
- Kurihara K, Nakanishi N, Amano O, Yamamoto M, Iseki S: Specific expression of an A-kinase anchoring protein subtype AKAP-150, and specific regulatory mechanism for Na + /K + -ATPase -ATPase via protein kinase A in the parotid gland among the three major salivary glands of the rat. Biochem Pharmacol 2003, 66: 239–250. 10.1016/S0006-2952(03)00259-4PubMedView ArticleGoogle Scholar
- Kurihara K, Nakanishi N, Amano O, Tonosaki K: Expression of Na + /K + -ATPase α subunit isoforms in rat salivary glands: occurrence of sense and antisense RNAs of the a3 isoform in the sublingual gland. Arch Oral Biol 2008, 53: 593–604. 10.1016/j.archoralbio.2008.01.007PubMedView ArticleGoogle Scholar
- Vesterberg O, Svensson H: Isoelectric fractionation, analysis and characterization of ampholytes in natural pH gradient. IV. Further studies on the resolving power in connection with separation of myoglobins. Acta Chem Scand 1966, 20: 820–834.PubMedView ArticleGoogle Scholar
- Kurihara K, Nakanishi N, Moore-Hoon ML, Turner RJ: Phosphorylation of the salivary Na + -K + -2Cl cotransporter. Am J Physiol (Cell Physiol) 2002, 282: C817-C823.View ArticleGoogle Scholar
- Kim J, Krichevsky A, Grad Y, Hayes GD, Kosik KS, Church GM, Ruvkun G: Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc Natl Acad Sci USA 2004, 101: 360–365. 10.1073/pnas.2333854100PubMed CentralPubMedView ArticleGoogle Scholar
- Landgrf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphort AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foa R, Schliwka J, Fuchs U, Novosel A, Muller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129: 1401–1414. 10.1016/j.cell.2007.04.040View ArticleGoogle Scholar
- Ahn HW, Morin RD, Zhao H, Harris RA, Coarfa C, Chen ZJ, Milosavljevic A, Marra MA, Rajkovic A: MicroRNA transcriptosome in the newborn mouse ovaries determined by massive parallel sequencing. Mol Hum Reprod 2010, 16: 463–471. 10.1093/molehr/gaq017PubMed CentralPubMedView ArticleGoogle Scholar
- Chiang HR, Schoenfeld LW, Ruby JG, Auyeung VC, Spies N, Baek D, Johnston WK, Russ C, Luo S, Babiarz JE, Blelloch R, Schroth GP, Nusbaum C, Bartel DP: Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 2010, 24: 992–1009. 10.1101/gad.1884710PubMed CentralPubMedView ArticleGoogle Scholar
- Fu X, Adamski M, Thompson EM: Altered miRNA repertoire in the simplified chordate, Oikopleura dioica . Mol Biol Evol 2008, 25: 1067–1080. 10.1093/molbev/msn060PubMedView ArticleGoogle Scholar
- Hosoi K, Maruyama S, Ueha T, Sato S, Gresik EW: Additive and/or synergistic effects of 5 alpha-dihydrotestosterone, dexamethasone, and triiodo-l-thyronine on induction of proteinases and epidermal growth factor in the submandibular gland of hypophysectomized mice. Endocrinol 1992, 130: 1044–1055. 10.1210/en.130.2.1044Google Scholar
- Kurabuchi S, Gresik EW, Hosoi K: Additive and/or synergistic action (downregulation) of androgens and thyroid hormones on the cellular distribution and localization of a true tissue kallikrein, mK1, in the mouse submandibular gland. J Histochem Cytochem 2004, 52: 1437–1446. 10.1369/jhc.4A6333.2004PubMed CentralPubMedView ArticleGoogle Scholar
- Friedman RC, Farh KK, Burge CB, Bratel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19: 92–105.PubMed CentralPubMedView ArticleGoogle Scholar
- He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM: A microRNA plycistron as a potential human oncogene. Nature 2005, 435: 828–833. 10.1038/nature03552PubMedView ArticleGoogle Scholar
- Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, Engelhardt S: MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456: 980–984. 10.1038/nature07511PubMedView ArticleGoogle Scholar
- Maes OC, Chertkow HM, Wang E, Schipper HM: MicroRNA: implications for Alzheimer disease and other human CNS disorders. Curr Genomics 2009, 10: 154–168. 10.2174/138920209788185252PubMed CentralPubMedView ArticleGoogle Scholar
- Faghihi MA, Zhang M, Huang J, Modarresi F, Van der Brug MP, Nalls MA, Cookson MR, St-Laurent G, Wahlestedt C: Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 2010, 11: R56. 10.1186/gb-2010-11-5-r56PubMed CentralPubMedView ArticleGoogle Scholar
- O'Day E, Lal A: MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 2010, 12: 201. 10.1186/bcr2484PubMed CentralPubMedView ArticleGoogle Scholar
- Choi EJ, Kim DH, Kim JG, Kim DY, Kim JD, Seol OJ, Jeong CS, Park JW, Choi MY, Kang SG, Costa ME, Ojeda SR, Lee BJ: Estrogen-dependent transcription of the NEL-LIKE 2 (NELL2) gene and its role in the protection of cell death. J Biol Chem 2010, 285: 5074–5084.Google Scholar
- Lee CH, Subramanian S, Beck AH, Espinosa I, Senz J, Zhu SX, Huntsman D, van de Rijin M, Gilks CB: MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary. PLoS One 2009, 4: e7314. 10.1371/journal.pone.0007314PubMed CentralPubMedView ArticleGoogle Scholar
- Cao P, Deng Z, Wan M, Huang W, Cramer SD, Xu J, Lei M, Sui G: MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol Cancer 2010, 9: 108. 10.1186/1476-4598-9-108PubMed CentralPubMedView ArticleGoogle Scholar
- Ober C, Loisel DA, Gilad Y: Sex-specific genetic architecture of human disease. Nat Rev Genet 2008, 9: 911–922. 10.1038/nrg2415PubMed CentralPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.